300 related articles for article (PubMed ID: 20624425)
1. Antiarrhythmic therapy in atrial fibrillation.
Ravens U
Pharmacol Ther; 2010 Oct; 128(1):129-45. PubMed ID: 20624425
[TBL] [Abstract][Full Text] [Related]
2. Novel pharmacological approaches for antiarrhythmic therapy.
Ravens U
Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):187-93. PubMed ID: 20082192
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of atrial fibrillation: a pathophysiological perspective and review.
Jacob S; Ali OA; Pidlaoan V; Badheka AO; Kerin NZ
Am J Ther; 2011 May; 18(3):241-60. PubMed ID: 20861719
[TBL] [Abstract][Full Text] [Related]
4. Electrical remodeling in atrial fibrillation.
Dobrev D
Herz; 2006 Apr; 31(2):108-12; quiz 142-3. PubMed ID: 16738832
[TBL] [Abstract][Full Text] [Related]
5. [Restoration and maintenance of sinus rhythm in patients with atrial fibrillation. New pharmacological approaches].
Runge S; Dietz R; Haverkamp W
Dtsch Med Wochenschr; 2008 Dec; 133(49):2572-8. PubMed ID: 19039713
[TBL] [Abstract][Full Text] [Related]
6. New pharmacological targets and treatments for atrial fibrillation.
Carlsson L; Duker G; Jacobson I
Trends Pharmacol Sci; 2010 Aug; 31(8):364-71. PubMed ID: 20605645
[TBL] [Abstract][Full Text] [Related]
7. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
[TBL] [Abstract][Full Text] [Related]
8. Vernakalant hydrochloride for the treatment of atrial fibrillation.
Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
Expert Opin Investig Drugs; 2009 Dec; 18(12):1929-37. PubMed ID: 19938903
[TBL] [Abstract][Full Text] [Related]
9. Cardiac ion channels and mechanisms for protection against atrial fibrillation.
Grunnet M; Bentzen BH; Sørensen US; Diness JG
Rev Physiol Biochem Pharmacol; 2012; 162():1-58. PubMed ID: 21987061
[TBL] [Abstract][Full Text] [Related]
10. Atria-selective antiarrhythmic drugs in need of alliance partners.
Peyronnet R; Ravens U
Pharmacol Res; 2019 Jul; 145():104262. PubMed ID: 31059791
[TBL] [Abstract][Full Text] [Related]
11. New pharmacological approaches to atrial fibrillation.
Milnes JT; Madge DJ; Ford JW
Drug Discov Today; 2012 Jul; 17(13-14):654-9. PubMed ID: 22370250
[TBL] [Abstract][Full Text] [Related]
12. [Cardiac two-pore-domain potassium channels (K2P): Physiology, pharmacology, and therapeutic potential].
Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D
Dtsch Med Wochenschr; 2012 Aug; 137(33):1654-8. PubMed ID: 22875694
[TBL] [Abstract][Full Text] [Related]
13. New drugs vs. old concepts: a fresh look at antiarrhythmics.
Thireau J; Pasquié JL; Martel E; Le Guennec JY; Richard S
Pharmacol Ther; 2011 Nov; 132(2):125-45. PubMed ID: 21420430
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of cardiac potassium channels.
Li GR; Dong MQ
Adv Pharmacol; 2010; 59():93-134. PubMed ID: 20933200
[TBL] [Abstract][Full Text] [Related]
15. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part I: Molecular and ionic fundamentals of antiarrhythmic drug actions.
Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
Ital Heart J; 2003 Jul; 4(7):430-41. PubMed ID: 14558293
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of the muscarinic potassium current by KB130015, a new antiarrhythmic agent to treat atrial fibrillation].
Borchard R; van Bracht M; Wickenbrock I; Prull MW; Pott L; Trappe HJ
Med Klin (Munich); 2005 Nov; 100(11):697-703. PubMed ID: 16328176
[TBL] [Abstract][Full Text] [Related]
17. Class 1 antiarrhythmic agents for therapy of atrial fibrillation.
Podrid PJ
Herz; 1993 Feb; 18(1):9-19. PubMed ID: 8454255
[TBL] [Abstract][Full Text] [Related]
18. New antiarrhythmic drugs for prevention of atrial fibrillation.
Goldstein RN; Stambler BS
Prog Cardiovasc Dis; 2005; 48(3):193-208. PubMed ID: 16271945
[TBL] [Abstract][Full Text] [Related]
19. New developments in atrial antiarrhythmic drug therapy.
Burashnikov A; Antzelevitch C
Nat Rev Cardiol; 2010 Mar; 7(3):139-48. PubMed ID: 20179721
[TBL] [Abstract][Full Text] [Related]
20. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation.
Savelieva I; Camm J
Nat Clin Pract Cardiovasc Med; 2008 Jan; 5(1):30-41. PubMed ID: 18094671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
